Twitter | Search | |
1stOncology
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.
13,750
Tweets
1,550
Following
1,060
Followers
Tweets
1stOncology 6h
Congratulates on the Start of Early Phase Clinical Trial
Reply Retweet Like
1stOncology 6h
Announces Clinical Supply Collaboration with on in Combination with (R) ()
Reply Retweet Like
1stOncology 6h
Holdings Announces Closing Of $3.5 Million Registered Priced At-the-Market
Reply Retweet Like
1stOncology 6h
and to Discontinue Study of in Relapsed and Refractory in Response to Public Health Crisis
Reply Retweet Like
1stOncology 6h
Posts Results of Collaborative Group Survey on the Management of Patients During the Pandemic
Reply Retweet Like
1stOncology 6h
submits new drug application for the targeted therapy in Taiwan for the treatment of adults with advanced
Reply Retweet Like
1stOncology 6h
Reports Supportive Efficacy Data from the Phase IIb Study; Overall Survival Data Expected in Late 2020
Reply Retweet Like
1stOncology 6h
receives positive opinion for ® () for the treatment of relapsed and refractory
Reply Retweet Like
1stOncology 6h
China's Pharma Lands $14 Million for Treatments
Reply Retweet Like
1stOncology 6h
Constitution of the Board of Directors in A/S, Grant of Restricted Stock Units to the New Member of the Board of Directors and a New Member of Management, and Grant of Restricted Stock Units and Warrants to Employees and a New Member
Reply Retweet Like
1stOncology 6h
Announces Publication in Science Translational Medicine of Preclinical Data Detailing a Potent and Selective Inhibitor of Overcoming Primary Resistance to
Reply Retweet Like
1stOncology Mar 27
Joins The 's Groundbreaking Beat Master Clinical Trial for Patients with
Reply Retweet Like
1stOncology Mar 27
Announces Initiation of Clinical Trial in Patients with
Reply Retweet Like
1stOncology Mar 27
Announces License and Commercialization Agreement with Co., Ltd. for in Japan and Other Asian Countries
Reply Retweet Like
1stOncology Mar 27
Inc. Announces It Has Reduced the Timeline of Its Personalized Process to Under Four Weeks
Reply Retweet Like
1stOncology Mar 27
Announces the Closing of Its $7.7 Million Bought Deal
Reply Retweet Like
1stOncology Mar 27
Announces Publication of Fourth Study Demonstrating Significant Impact of on Treatment Plan Recommendations for Patients with
Reply Retweet Like
1stOncology Mar 27
’s Study with in Shows Strong Progression-Free Survival Treatment Effect Utilizing Medidata Synthetic Control Arm
Reply Retweet Like
1stOncology Mar 27
Pharmaceuticals Receives Nasdaq Bid Price Extension
Reply Retweet Like
1stOncology Mar 27
announces leading U.S. center to use ™ cloud-based tool for sequencing data interpretation and reporting
Reply Retweet Like